Events

Rappel de PEDI-CAP PEDIATRIC END-TIDAL CO2 DETECTOR

Selon Health Canada (via FOI), ce/cet/cette rappel concerne un dispositif en/au/aux/à Canada qui a été fabriqué par COVIDIEN LP - RESPIRATORY & MONITORING SOLUTIONS GBU.

Qu'est-ce que c'est?

Une correction ou un retrait opéré par un fabricant afin de répondre à un problème causé par un dispositif médical. Les rappels surviennent lorsqu'un dispositif médical est défectueux, lorsqu'il pourrait poser un risque pour la santé, ou les deux à la fois.

En savoir plus sur les données ici
  • Type d'événement
    Recall
  • ID de l'événement
    49308
  • Classe de risque de l'événement
    I
  • Date de mise en oeuvre de l'événement
    2009-08-20
  • Pays de l'événement
    Canada
  • Source de l'événement
    HC
  • Notes / Alertes
    Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
  • Notes supplémentaires dans les données
  • Cause
    A recent modification to pedicap end-tidal co2 detector may result in increased resistance to airflow through pedicap and may cause ineffective ventilation of patient and inadequate detection of co2 levels so that the indicator paper will not change color.

Device

PEDI-CAP PEDIATRIC END-TIDAL CO2 DETECTOR
  • Modèle / numéro de série
    Model Catalog: PEDICAP 6 (Lot serial: >10 NUMBERS CONTACT MFG); Model Catalog: PEDICAP (Lot serial: >10 NUMBERS CONTACT MFG)
  • Description du dispositif
    PEDICAP/PEDICAP 6
  • Manufacturer
    COVIDIEN LP - RESPIRATORY & MONITORING SOLUTIONS GBU

Manufacturer

COVIDIEN LP - RESPIRATORY & MONITORING SOLUTIONS GBU
  • Adresse du fabricant
    BOULDER
  • Société-mère du fabricant (2017)
    Medtronic plc
  • Commentaire du fabricant
    “If our surveillance systems identify a potential performance issue, our personnel promptly evaluate the problem, including, when appropriate, conducting root cause investigations and internal testing to assess whether the product continues to meet specifications and defined performance criteria,” Medtronic told ICIJ in a statement. “In some cases, based on this evaluation, Medtronic may determine that a recall is necessary.” The company said that it communicates with healthcare providers and/or patients and provide recommendations to address such issues. Medtronic noted that these communications can include letters, emails, calls, press releases, physician notifications and social media postings, as well as informing the FDA and other regulators of the actions.
  • Source
    HC